Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2010
08/25/2010EP1263722B1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
08/25/2010EP1263721B1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
08/25/2010EP1181047B9 Composition comprising alkaline sphingomyelinase of bacterial origin for use as a dietetic preparation, food supplement or pharmaceutical product
08/25/2010CN1997619B Phenyl derivatives comprising an acetylene group
08/25/2010CN1872112B Drop pills of total saponin of gen-seng haulms, and preparation method
08/25/2010CN1861595B Brugine cyclo hexathio-alcohol kind compound, its preparation process and use
08/25/2010CN1785285B Extraction method of hawthorn leaf
08/25/2010CN101815716A Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
08/25/2010CN101815704A Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1
08/25/2010CN101815443A Foodstuff of tablets or capsules
08/25/2010CN101812190A Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same
08/25/2010CN101812189A Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same
08/25/2010CN101812136A Method for preparing astragalus polysaccharide extract
08/25/2010CN101812118A Specific binding agents of human angiopoietin-2
08/25/2010CN101812043A C-aryl glucoside derivative, preparation method thereof and application thereof in medicine
08/25/2010CN101810859A Medical composition containing aniline derivative
08/25/2010CN101810849A Medicament for curing diabetes
08/25/2010CN101810845A Nutritional agent for enhancing immunity, restoring gastrointestinal function and protecting heart, brain, liver and kidney cells
08/25/2010CN101810793A Application of corn stigma flavone in preparing medicament for curing hyperlipidemia and losing weight
08/25/2010CN101810782A Medicament for treating diabetes
08/25/2010CN101810778A Chinese medicinal composition for treating diabetes and preparation method thereof
08/25/2010CN101810775A Chinese medicinal composition for reducing sugar and dripping pills
08/25/2010CN101810762A Method for preparing diabetes diet therapy medicament
08/25/2010CN101810750A Hyperglycemic Chinese herb preparation containing papaya milk powder
08/25/2010CN101810735A Method for extracting total flavone from ampelopsis grossedentata
08/25/2010CN101810713A Medicament for treating hyperlipemia
08/25/2010CN101810665A Use of yuenkanin organic acid for preparing weight-losing and blood lipid-lowering medicine
08/25/2010CN101810664A Use of yuenkanin total saponins for preparing weight-losing and blood lipid-lowering medicine
08/25/2010CN101810663A Use of yuenkanin extract for preparing slimming blood lipid-lowering medicine
08/25/2010CN101810660A Water-soluble silymarin and preparation method thereof
08/25/2010CN101810659A Total saponins of salvia chinensis benth, and medical application and preparation method thereof
08/25/2010CN101810654A Application of vinegar-prepared radix bupleuri solvent extract in cholesterol-reducing drug preparation
08/25/2010CN101810649A Method for preparing pine needle distilled and concentrated solution
08/25/2010CN101810637A Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same
08/25/2010CN101810636A Application of Chinese yam polysaccharide in preparation of medicament for treating obesity
08/25/2010CN101810628A Melbine glipizide tablet and preparation method thereof
08/25/2010CN101810625A Application of taraxasterol
08/25/2010CN101810599A Application of resveratrol in preparing medicines for preventing and curing vessel endothelial injuries caused by organophosphorus pesticides
08/25/2010CN101810585A Invertose (fructose/glucose) medicinal composition microsphere injection
08/25/2010CN101402600B Process for producing vitamin B6
08/25/2010CN101322737B Persimmon leaf flavones extract and preparation thereof
08/25/2010CN101229316B Rhizoma anemarrhenae extrac
08/25/2010CN101210011B Quinolines compounds and their intermediates, preparation method and application
08/25/2010CN101199817B Liver-protecting fat-dropping tea
08/25/2010CN101147584B Health-care food capable of preventing and treating diabetes and preparation method thereof
08/25/2010CN101129460B Alpha-glucosidase inhibitor-prunella spike extractive and method for extracting the same
08/25/2010CN101108252B Pharmaceutical composition of cyclodextrin dragon's blood and method of preparing the same
08/25/2010CN101065119B Ameliorant for renal insufficiency
08/25/2010CN101044908B High nutrition product developed from vertebra bone of freshwater eel
08/25/2010CN101044902B Health-care product for reducing weight and lowering cholesterin content in blood
08/24/2010US7781596 Substituted 2-phenylbenzimidazoles, the production thereof and their use
08/24/2010US7781584 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
08/24/2010US7781468 peroxisome proliferator-activated receptor (PPAR) agonists such as (2S)-3-{-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-ethoxy]-phenyl}-2-(3-phenyl-acryloylamino)-propionic acid, used for the treatment of hyperglycemia, dyslipidemia, non-insulin dependent diabetes and hyperlipemia
08/24/2010US7781463 Enzyme inhibitors
08/24/2010US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents
08/24/2010US7781455 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; dipeptidylpeptidase-IV enzyme inhibitors; diabetes
08/24/2010US7781450 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer
08/24/2010US7781440 Neurodegenerative diseases caused by GSK3 such as Alzheimer's disease
08/24/2010US7781408 Oral administration of gangliosides including 50% ganglioside GD3 as anticholesterol and antiinflammatory agents; decreased intestinal absorption of cholesterol; mediating inflammation of the intestine, retina or neural tissues; liquid or food suppliment for infants
08/24/2010US7780988 Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
08/24/2010CA2582049C Bilayer tablet comprising telmisartan and amlodipine
08/24/2010CA2507749C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/24/2010CA2467857C Piperidine-based mch antagonists for treatment of obesity and cns disorders
08/24/2010CA2460135C Use of pyridazinone compounds as phosphodiesterase iv inhibitors for treating cancer and other diseases
08/24/2010CA2430122C Antiobesity agent and health food
08/24/2010CA2348493C Textured and porous silicone rubber
08/24/2010CA2334858C Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression
08/20/2010CA2655949A1 A method for treating hypercholesterolemic, hypertriglyceridemic, hyperlipidemic and/or dyslipidemic conditons and their related complications linked to metabolic disorders such as obesity and diabetes, using a crude plant extract from the genus tabernaemontana (peschiera), namely peschiera fuchsiaefolia, alone or combined with other therapeutics
08/19/2010WO2010093845A1 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
08/19/2010WO2010093802A2 Therapeutic method for increasing pancreatic beta cell mass
08/19/2010WO2010093784A2 Modified virus vectors and methods of making and using the same
08/19/2010WO2010093634A1 Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia
08/19/2010WO2010093601A1 Novel sulfonic acid-containing thyromimetics, and methods for their use
08/19/2010WO2010093322A1 Methods for identifying therapeutic agents modulating activity of the igf2 repressor zbed6
08/19/2010WO2010093243A1 Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders
08/19/2010WO2010092386A1 Crystalline polymorphic form 631
08/19/2010WO2010092289A1 3-benzofuranyl-indol-2-one derivatives substituted at the 3 position, preparation thereof, and therapeutic use thereof
08/19/2010WO2010092288A1 Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof
08/19/2010WO2010092163A2 Antidiabetic medications
08/19/2010WO2010092154A1 Novel substituted indanes, method for the production thereof, and use thereof as drugs
08/19/2010WO2010092153A1 New substituted tetrahydronapthalenes, method for the production thereof, and use thereof as drugs
08/19/2010WO2010092126A1 Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
08/19/2010WO2010092125A1 Pharmaceutical composition comprising a sglt2 inhibitor, a dpp-iv inhibitor and optionally a further antidiabetic agent and uses thereof
08/19/2010WO2010092124A1 Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
08/19/2010WO2010092123A1 Sglt-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabete mellitus, impaired glucose tolerance or hyperglycemia
08/19/2010WO2010092090A2 Novel salts of sitagliptin
08/19/2010WO2010091981A2 Products comprising n-phenylpropenoyl amino acid amides and uses thereof
08/19/2010WO2010072647A3 Dihydropyridone amides useful as medicaments for the treatment of autoimmune and inflammatory diseases
08/19/2010WO2010068414A9 Methods for treating obesity related disease
08/19/2010WO2010060041A3 Phenylalanine amide inhibitors of atp-sensitive potassium channels
08/19/2010WO2010055490A3 Phytocomplex from bergamot fruit, process of manufacture and use as dietary supplement and in the pharmaceutical field
08/19/2010WO2010054326A3 C-terminal fragments of glucagon-like peptide-1 (glp-1)
08/19/2010WO2010054001A3 D-tagatose-based compositions and methods for preventing and treating atherosclerosis, metabolic syndrome, and symptoms thereof
08/19/2010WO2010004584A3 Process for production of anti-diabetic compound in root culture of catharanthus roseus
08/19/2010WO2009135581A3 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
08/19/2010WO2009061453A8 Solubilized thiazolopyridines
08/19/2010US20100211015 Composition comprising hyaluronidase glycoprotein that is active at neutral pH and contains at least one sugar moiety that is covalently attached to an asparagine for use in treatment of diabetic disorders
08/19/2010US20100210838 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
08/19/2010US20100210734 Method of using calcitriol for treating intraocular diseases associated with angiogenesis
08/19/2010US20100210727 Hepoxilin analog enantiomers
1 ... 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 ... 1298